The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Walgreen Co

NYSE: WAG
Last

(U.S.) $73.23

Today's change-1.15 -1.55%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
 

Walgreen Co

NYSE: WAG
Last

(U.S.) $73.23

Today's change-1.15 -1.55%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Walgreen Co down (U.S.)$1.15

Walgreen Co closed sharply lower Friday, dropping (U.S.)$1.15 or 1.55% to (U.S.)$73.23. Shares have lost 1.70% over the last five days, but sit 4.14% below their 52-week high. This security has outperformed the S&P 500 by 14.18% during the last year.

Key company metrics

  • Open(U.S.) $73.95
  • Previous close(U.S.) $74.38
  • High(U.S.) $74.50
  • Low(U.S.) $73.05
  • Bid / Ask-- / --
  • YTD % change+27.49%
  • Volume9,320,798
  • Average volume (10-day)8,647,090
  • Average volume (1-month)5,990,124
  • Average volume (3-month)6,034,016
  • 52-week range(U.S.) $54.86 to (U.S.) $76.39
  • Beta1.35
  • Trailing P/E36.59×
  • P/E 1 year forward20.44×
  • Forward PEG1.29×
  • Indicated annual dividend(U.S.) $1.35
  • Dividend yield1.84%
  • Trailing EPS(U.S.) $2.00
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
S&P TSX0.85%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedAug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014Nov 30, 201311/30/2013
Revenue19,05719,40119,60518,329
Total other revenue--------
Total revenue19,05719,40119,60518,329
Gross profit5,3275,4405,6505,152
Total cost of revenue13,73013,96113,95513,177
Total operating expense18,08818,37518,33017,405
Selling / general / administrative4,4034,5074,5634,352
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)9044627
Other operating expenses, total--------
Operating income9691,0261,275924
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1551,1151,1791,108
Income after tax-205764768704
Income tax, total360351411404
Net income-239722754695
Total adjustments to net income--------
Net income before extra. items-239722754695
Minority interest-34-42-14-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-239722754695
Inc. avail. to common incl. extra. items-239722754695
Diluted net income-239722754695
Dilution adjustment0------
Diluted weighted average shares956968964962
Diluted EPS excluding extraordinary itemsvalue per share-0.250.750.780.72
Dividends per sharevalue per share0.320.320.320.32
Diluted normalized EPSvalue per share-0.030.810.800.75